Provided by Tiger Trade Technology Pte. Ltd.

Illumina

129.56
-3.3300-2.51%
Pre-market: 128.81-0.7500-0.58%04:06 EST
Volume:1.44M
Turnover:185.88M
Market Cap:19.80B
PE:23.77
High:131.32
Open:129.69
Low:127.11
Close:132.89
52wk High:155.53
52wk Low:68.70
Shares:152.80M
Float Shares:149.35M
Volume Ratio:0.51
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.45
EPS(LYR):5.45
ROE:33.36%
ROA:8.39%
PB:7.27
PE(LYR):23.77

Loading ...

Has Illumina’s Rally After Grail Divestiture Put Its Valuation Back on Track?

Simply Wall St.
·
Oct 21, 2025

Illumina Faces Competitive Threat from Roche’s SBX Platform: Analyst Issues Sell Rating

TIPRANKS
·
Oct 20, 2025

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

prnewswire
·
Oct 17, 2025

Roche Sets Gene-Sequencing Record. It's a Challenge for Illumina. -- Barrons.com

Dow Jones
·
Oct 17, 2025

Stock Track | Illumina Stock Soars 5.05% on Launch of Revolutionary 5-Base Solution for Genomic Research

Stock Track
·
Oct 16, 2025

Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX) and Illumina (ILMN)

TIPRANKS
·
Oct 16, 2025

Stock Track | Illumina Soars 5.04% on Breakthrough Technologies and AI Healthcare Potential

Stock Track
·
Oct 15, 2025

Stock Track | Illumina Soars 5.04% on Breakthrough Technologies and AI Potential in Healthcare

Stock Track
·
Oct 15, 2025

BRIEF-Illumina Constellation Mapped Read Technology Uncovers Hard-To-See Genomic Insights In GeneDx Pilot

Reuters
·
Oct 15, 2025

Illumina's New Constellation Technology Outperforms Traditional Methods in GeneDx Clinical Study for Rare Disease Genomics

Reuters
·
Oct 15, 2025

Illumina Constellation Mapped Read Technology Uncovers Hard-to-See Genomic Insights in GeneDx Pilot

THOMSON REUTERS
·
Oct 15, 2025

Illumina Inc - Constellation-Based Product Release Slated for First Half of 2026

THOMSON REUTERS
·
Oct 15, 2025

Illumina Unveils 5-Base Solution Enabling Simultaneous Genomic and Epigenomic Analysis for Rare Disease Research

Reuters
·
Oct 15, 2025

Illumina Fuels Multiomic Discovery With Launch of 5-Base Solution, Unlocking Simultaneous Genomic and Epigenomic Insights

THOMSON REUTERS
·
Oct 15, 2025

Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns

Benzinga_recent_news
·
Oct 15, 2025

Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025

THOMSON REUTERS
·
Oct 15, 2025

Stock Track | Illumina Stock Plummets 5.11% as China's Ban on Genetic Sequencers Intensifies Trade War Impact

Stock Track
·
Oct 14, 2025

Stock Track | Illumina Shares Plummet 5.11% as China Bans Import of Company's Genetic Sequencers

Stock Track
·
Oct 14, 2025

Illumina Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Oct 08, 2025

Illumina (ILMN) Gets a Sell from Citi

TIPRANKS
·
Oct 07, 2025